ECG Buddy Clinic Downloads & RevenueECG Buddy Clinic: CVD Risk AI · App Store
ECG Buddy Clinic - 심혈관 고위험군 선별
Not in any tracked top chart right now.
Updated 9 Nov 2026 · rankings refresh through the day
DeveloperARPI Inc
CategoryMedical
PriceFree
Released
Rating★ 0.0 (0)
Versionv1.1.1
Age rating17+
First seen by us
31 Oct 2026
ECG Buddy Clinic: CVD Risk AI update history & changes
Last change · 3 events since 13 Jan 2026Full timeline ↓Full timeline · 3 events
- 🆕ECG Buddy Clinic: CVD Risk AI first spotted by AppInsider#52 in Top Free · Medical · South Korea
- 📦ECG Buddy Clinic: CVD Risk AI version v1.1.1• Improved app stability and performance
• More reliable sign-in sessions
• Better layout on large screens (foldables and tablets)
• Bug fixes - 🆕ECG Buddy Clinic: CVD Risk AI released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
Rating
0.0 ★
0 ratings
Measured
ECG Buddy Clinic: CVD Risk AI on the App Store
App details
App ID
1661493557
Publisher
ARPI Inc
On the store since
Jan 2026
Under a year
Minimum OS
iOS 15.0+
iPhone 6s and later
Devices
iPhone · iPad
Content rating
17+
Languages
1
EN
Size
90 MB
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Not charting right now. | ||
Ratings
App Store, worldwide.
Rating
0.0 ★
0 ratings
Measured
Ratings
0
Measured
About ECG Buddy Clinic: CVD Risk AI
Supports screening of hidden high-risk cardiovascular patients in outpatient care, from a single 12-lead ECG.
ECG Buddy Clinic is a Korean MFDS-approved Class III software medical device. Capture a 12-lead ECG with your smartphone, and the AI provides an estimated LVEF and risk scores for 4 digital biomarkers. It reveals possible structural and functional abnormalities beyond standard ECG interpretation, and supports decisions on follow-up tests such as echocardiography or coronary CT.
[Estimated LVEF]
• Estimated LVEF (%) from the ECG alone
• A key reference for identifying heart failure risk and reduced LV systolic function
[4 Digital Biomarkers]
• CADS: coronary artery disease with ≥50% stenosis
• PAF: paroxysmal AF risk from sinus rhythm ECGs
• LVH: a major complication of chronic hypertension
• HCM: a cause of sudden cardiac death
• Risk levels shown at a glance in a graph
[Easy to Use]
• Automatic ECG area detection on the camera screen
• Works with printed ECGs, ECGs on monitors, and saved ECG images
• No extra equipment or hospital system integration needed
[Validated Technology]
• Korean MFDS-approved Class III medical device
• Validated in 6 peer-reviewed papers, including Heart Rhythm and European Heart Journal Digital Health
• ISO 27001 and ISO 27701 certified
[Usage Policy]
• Up to 10 analyses per day
• Subject to change with prior notice if a subscription is introduced
[Precautions]
• Please read the "Instructions for Use" before clinical application.
• Clinical use is restricted to countries where regulatory approval has been granted (Republic of Korea, Vietnam). For educational and research purposes, use should be limited to post-case reviews and educational interpretations.
• For clinical use, this device is intended for physicians capable of interpreting 12-lead ECGs or medical personnel who transmit results to such physicians.
• This tool is designed to support diagnostic and treatment decisions and can never replace the professional medical judgment of a physician.
*For any inquiries or for more information, please visit our website (www.arpi.ai).
ECG Buddy Clinic is a Korean MFDS-approved Class III software medical device. Capture a 12-lead ECG with your smartphone, and the AI provides an estimated LVEF and risk scores for 4 digital biomarkers. It reveals possible structural and functional abnormalities beyond standard ECG interpretation, and supports decisions on follow-up tests such as echocardiography or coronary CT.
[Estimated LVEF]
• Estimated LVEF (%) from the ECG alone
• A key reference for identifying heart failure risk and reduced LV systolic function
[4 Digital Biomarkers]
• CADS: coronary artery disease with ≥50% stenosis
• PAF: paroxysmal AF risk from sinus rhythm ECGs
• LVH: a major complication of chronic hypertension
• HCM: a cause of sudden cardiac death
• Risk levels shown at a glance in a graph
[Easy to Use]
• Automatic ECG area detection on the camera screen
• Works with printed ECGs, ECGs on monitors, and saved ECG images
• No extra equipment or hospital system integration needed
[Validated Technology]
• Korean MFDS-approved Class III medical device
• Validated in 6 peer-reviewed papers, including Heart Rhythm and European Heart Journal Digital Health
• ISO 27001 and ISO 27701 certified
[Usage Policy]
• Up to 10 analyses per day
• Subject to change with prior notice if a subscription is introduced
[Precautions]
• Please read the "Instructions for Use" before clinical application.
• Clinical use is restricted to countries where regulatory approval has been granted (Republic of Korea, Vietnam). For educational and research purposes, use should be limited to post-case reviews and educational interpretations.
• For clinical use, this device is intended for physicians capable of interpreting 12-lead ECGs or medical personnel who transmit results to such physicians.
• This tool is designed to support diagnostic and treatment decisions and can never replace the professional medical judgment of a physician.
*For any inquiries or for more information, please visit our website (www.arpi.ai).
Latest updates
v1.1.1
• Improved app stability and performance
• More reliable sign-in sessions
• Better layout on large screens (foldables and tablets)
• Bug fixes